Bill Sponsor
House Bill 6599
116th Congress(2019-2020)
Computing Opportunities to Vanquish Infectious Diseases Research Act of 2020
Introduced
Introduced
Introduced in House on Apr 23, 2020
Overview
Text
Introduced
Apr 23, 2020
Latest Action
Apr 23, 2020
Origin Chamber
House
Type
Bill
Bill
The primary form of legislative measure used to propose law. Depending on the chamber of origin, bills begin with a designation of either H.R. or S. Joint resolution is another form of legislative measure used to propose law.
Bill Number
6599
Congress
116
Policy Area
Health
Health
Primary focus of measure is science or practice of the diagnosis, treatment, and prevention of disease; health services administration and funding, including such programs as Medicare and Medicaid; health personnel and medical education; drug use and safety; health care coverage and insurance; health facilities. Measures concerning controlled substances and drug trafficking may fall under Crime and Law Enforcement policy area.
Sponsorship by Party
House Votes (0)
Senate Votes (0)
No House votes have been held for this bill.
Summary

COVID Research Act of 2020 or the Computing Opportunities to Vanquish Infectious Diseases Research Act of 2020

This bill requires the Office of Science and Technology Policy (OSTP) and the Department of Energy (DOE) to undertake specified actions related to forecasting emerging infectious diseases.

The OSTP, acting through the National Science and Technology Council, must establish an interagency working group to coordinate federal activities concerning infectious disease prediction and forecasting. Among other tasks, the working group must identify challenges in predicting outbreaks and develop a strategic plan to address them.

The bill also provides statutory authority for the Standing Committee on Emerging Infectious Diseases and 21st Century Health Threats convened by the National Academies of Sciences, Engineering, and Medicine. The committee must provide expertise to the working group and otherwise facilitate science and policy discussions concerning emerging infectious diseases. The committee must issue public reports and brief Congress on its activities.

In coordination with specified entities, DOE shall carry out, and report to Congress on, a competitive research program for the National Laboratories and others to leverage analytical tools and computational and networking capabilities to prevent and respond to emerging infectious diseases, including COVID-19 (i.e., coronavirus disease 2019). DOE must also establish the Emerging Infectious Diseases High Performance Computing Research Consortium to support the research program.

Text (1)
April 23, 2020
Actions (2)
04/23/2020
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Science, Space, and Technology, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
04/23/2020
Introduced in House
Public Record
Record Updated
Jan 11, 2023 1:43:07 PM